Skip to content
Myhep all

Mylan

Myhep all


"MYHEP ALL" contains Drug / Molecule called “Velpatasvir & Sofosbuvir”. MYHEP ALL has high overall cure rates of 99% for GT2 patients† and 95% for GT3 patients‡. Velpanat was also found to be highly effective in patients with GT1, GT4, GT5 and GT6, with overall cure rates ranging from 97–100%.

  


Indication

MYHEP ALL is helpful for treatment of all Hepatitis C adults that are suffering from genotype 1-6 chronic hepatitis C virus.

Note

Precaution

  • Myhep All is a prescription drug and should be used under proper medical guidance and advice.
  • Caution should be exercised in patients with history of stomach problem, liver, kidney, or heart disease during pregnancy and breastfeeding.

 

Updated On Oct 17, 2019 by Admin

Strength

100 mg Velpatasvir / 400 mg Sofosbuvir

Packing

1*28 Tablets (Bottle)

Storage

Store at room temperature (25 C).



Related Products


NATCO PHARMA LIMITED (INDIA)

Velpanat

NATCO PHARMA LIMITED (INDIA)

Sofosbuvir & velpatasvir-velpanat

Hetero Healthcare Ltd. (INDIA)

Ledifos

Mylan

Mydacla


Most Viewed Products


CIPLA LTD. (INDIA)

Abiraterone acetate-xbira

NATCO PHARMA LIMITED (INDIA)

Bendamustine-bendit

CIPLA LTD. (INDIA)

Bicalutamide-cassotide

NATCO PHARMA LIMITED (INDIA)

Bortezomib-bortenat

NATCO PHARMA LIMITED (INDIA)

Erlonat

Biocon Limited

Everolimus-evertor

NATCO PHARMA LIMITED (INDIA)

Exemestane-xtane

NATCO PHARMA LIMITED (INDIA)

Geftinat

NATCO PHARMA LIMITED (INDIA)

Glatiramer acetate-glatimer

NATCO PHARMA LIMITED (INDIA)

Ledipasvir & sofosbuvir-hepcinat lp

NATCO PHARMA LIMITED (INDIA)

Lenalidomide-lenalid

NATCO PHARMA LIMITED (INDIA)

Pomalidomide-pomalid

NATCO PHARMA LIMITED (INDIA)

Sofosbuvir & velpatasvir-velpanat

NATCO PHARMA LIMITED (INDIA)

Sorafenib-sorafenat

CIPLA LTD. (INDIA)

Tenofovir-tenvir

Quick Query

Direct to your Phone